| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enveric Biosciences, Inc. (ENVB) has 7 insiders with recent SEC Form 4 filings, including 15 buys and 0 sells. ENVB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 70.4K | $200.5K | - | |
| CFO | 47.4K | $135.1K | - | |
| Dir | 7.9K | $22.5K | - | |
| Dir | 7.9K | $22.5K | - | |
| Dir | 7.9K | $22.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2016 | Eberwein Jeffrey E.66 | - | Buy | 89 | $6.00 | $534.00 | +0.2% | |
| Feb 2, 2016 | Eberwein Jeffrey E.66 | - | Buy | 2,600 | $6.01 | $15,626.00 | +6.9% | |
| Jan 8, 2016 | Eberwein Jeffrey E.66 | - | Buy | 5,304 | $6.01 | $31,877.04 | +8.1% | |
| Dec 18, 2015 | Eberwein Jeffrey E.66 | - | Buy | 8,032 | $6.01 | $48,272.32 | +14.6% | |
| Dec 16, 2015 | Eberwein Jeffrey E.66 | - | Buy | 10,631 | $6.01 | $63,892.31 | +38.5% | |
| Dec 14, 2015 | Eberwein Jeffrey E.66 | - | Buy | 558 | $6.01 | $3,353.58 | +2.2% | |
| Dec 10, 2015 | Eberwein Jeffrey E.66 | - | Buy | 2,759 | $6.01 | $16,581.59 | +13.0% | |
| Jul 16, 2015 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 1,249 | $1.50 | $1,873.50 | +14.1% | |
| Jul 13, 2015 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 2,500 | $2.51 | $6,275.00 | +39.2% | |
| Jul 8, 2015 | Eberwein Jeffrey E.66 | Director, 10% Owner | Buy | 1,368 | $2.51 | $3,433.68 | +27.3% |